Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin.
Urology. 1994 Aug;44(2):237-42. doi: 10.1016/s0090-4295(94)80138-x.
Urology. 1994.
PMID: 7519382
Free article.
Clinical Trial.
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.
Sarkis AS, Bajorin DF, Reuter VE, Herr HW, Netto G, Zhang ZF, Schultz PK, Cordon-Cardo C, Scher HI.
Sarkis AS, et al. Among authors: schultz pk.
J Clin Oncol. 1995 Jun;13(6):1384-90. doi: 10.1200/JCO.1995.13.6.1384.
J Clin Oncol. 1995.
PMID: 7751883
Item in Clipboard
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.
Schultz PK, Herr HW, Zhang ZF, Bajorin DF, Seidman A, Sarkis A, Fair WR, Scherr D, Bosl GJ, Scher HI.
Schultz PK, et al.
J Clin Oncol. 1994 Jul;12(7):1394-401. doi: 10.1200/JCO.1994.12.7.1394.
J Clin Oncol. 1994.
PMID: 8021730
Item in Clipboard
Cite
Cite